Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Korean Committee Recommends Bill Allowing OTC Supermarket Sales

This article was originally published in The Tan Sheet

Executive Summary

The law could go into effect as early as August to allow sales of 20 types of OTC drugs – painkillers, cold medicines, digestive products and fever reducers – beyond the traditional outlet of pharmacies.

You may also be interested in...



Korean Lawmakers Focus On Elections, Pass On Expanding OTC Sales

The Health Ministry’s bill to allow sales of some OTC products in supermarkets looks doomed as lawmakers leave to prepare for upcoming elections. If the ministry wants the Assembly to consider the change next year, it would have to restart the process.

Korean Lawmakers Focus On Elections, Pass On Expanding OTC Sales

The Health Ministry’s bill to allow sales of some OTC products in supermarkets looks doomed as lawmakers leave to prepare for upcoming elections. If the ministry wants the Assembly to consider the change next year, it would have to restart the process.

In Brief

FDA proposes amending ANDA-blocking petition reg; Sara Lee snaps up Tea Forté; testing by FDA, CDC find no bacteria in Enfamil formula powder; USP offers draft probiotics standards; more news In Brief.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105575

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel